(Q40135330)

17 September 2017

title

Differential effects of bexarotene on intrinsic and extrinsic pathways in TRAIL-induced apoptosis in two myeloid leukemia cell lines (English)

1 reference

17 September 2017

9

H J Deeg

1 reference

17 September 2017

5

Hans-Peter Kiem

1 reference

17 September 2017

8

Ajay K Gopal

1 reference

17 September 2017

3

Nissa Abbassi

1 reference

17 September 2017

4

David M Hockenbery

1 reference

17 September 2017

Shao Xu Ying

1

1 reference

17 September 2017

Sudeshna Seal

series ordinal

2

1 reference

17 September 2017

Xiao Li

series ordinal

6

1 reference

17 September 2017

John M Pagel

series ordinal

7

1 reference

17 September 2017

publication date

1 May 2007

1 reference

17 September 2017

1 reference

17 September 2017

volume

48

1 reference

17 September 2017

issue

5

1 reference

17 September 2017

page(s)

1003-1014

1 reference

Identification and characterization of a new member of the TNF family that induces apoptosis

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

TRAIL regulates normal erythroid maturation through an ERK-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

The CD95 type I/type II model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Differential modulation of apoptosis sensitivity in CD95 type I and type II cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Cross-talk in cell death signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Two CD95 (APO-1/Fas) signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Inhibition of death receptor signals by cellular FLIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Resistance to TRAIL-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

TRAIL-induced signalling and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Sensitization of prostate carcinoma cells to Apo2L/TRAIL by a Bcl-2 family protein inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Sodium butyrate sensitizes human glioma cells to TRAIL-mediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Mechanisms of resistance to TRAIL-induced apoptosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Differential involvement of Bax and Bak in TRAIL-mediated apoptosis of leukemic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

N-(4-hydroxyphenyl) retinamide (4HPR) enhances TRAIL-mediated apoptosis through enhancement of a mitochondrial-dependent amplification loop in ovarian cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Activation of retinoid X receptors induces apoptosis in HL-60 cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Drug approval summaries: arsenic trioxide, tamoxifen citrate, anastrazole, paclitaxel, bexarotene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Optimizing bexarotene therapy for cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Bexarotene is a new treatment option for lymphomatoid papulosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Emerging role of rexinoids in non-small cell lung cancer: focus on bexarotene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

New biological agents in the treatment of advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Chelerythrin activates caspase-8, downregulates FLIP long and short, and overcomes resistance to tumour necrosis factor-related apoptosis-inducing ligand in KG1a cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Expression of FLIPLong and FLIPShort in bone marrow mononuclear and CD34+ cells in patients with myelodysplastic syndrome: correlation with apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

NF-kappaB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Nitrogen cavitation for cell disruption to obtain mitochondria from cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Selective roles of retinoic acid receptor and retinoid x receptor in the suppression of apoptosis by all-trans-retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Coactivation of liver receptor homologue-1 by peroxisome proliferator-activated receptor gamma coactivator-1alpha on aromatase promoter II and its inhibition by activated retinoid X receptor suggest a novel target for breast-specific antiestrogen th

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

Promoting apoptosis as a strategy for cancer drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

TRAIL and its receptors as targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

TRAIL and malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

TRAIL and chemotherapeutic drugs in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

On the TRAIL of a new therapy for leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701242358

10.1080/10428190701242358

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference